-
Archives
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- November 2015
- September 2015
- July 2015
- June 2015
- February 2015
- October 2014
- August 2014
- March 2014
- January 2014
- September 2013
- August 2013
- June 2013
- May 2013
- March 2013
- February 2013
- December 2012
- November 2012
- August 2012
- July 2012
- June 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- April 2011
- March 2011
- February 2011
- January 2011
-
Meta
Monthly Archives: April 2012
New Clinical Study Evaluates First Drug to Show Improvement in Subtype of Autism
Researchers at the Seaver Autism Center, led by Dr. Alex Kolevzon, have begun a clinical trial to evaluate insulin-like growth factor in children who have SHANK3 deficiency, a known cause of autism spectrum disorder. Click here to read the press … Continue reading
Posted in News
Comments Off on New Clinical Study Evaluates First Drug to Show Improvement in Subtype of Autism